Hi there!
We track 68,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Vistim Labs turns a single EEG into PET-like estimates of amyloid, tau, and cognitive decline so clinicians can monitor dementia progression and therapy response. Their B2B SaaS product, CASBA ATN+,…

Vistim Labs turns a single EEG into PET-like estimates of amyloid, tau, and cognitive decline so clinicians can monitor dementia progression and therapy response. Their B2B SaaS product, CASBA ATN+,…
Tech: EEG-based PET-like biomarker estimation (amyloid, tau, neurodegeneration) via AI/ML
Product: CASBA ATN+ / Ceregram — in-clinic, noninvasive longitudinal brain monitoring
Founded: 2021
HQ / Bases: United States (Salt Lake City listed); additional bases referenced (Miami, San Diego) and affiliates (New York, Paris, Berlin)
Funding: Grant-backed funding; total reported ~$817,000
Neurodegenerative disease monitoring and clinical/research brain mapping
2021
Biotechnology Research
Multiple grant funding transactions listed; Crunchbase classifies last round as Grant with Alberta Innovates as lead
“Alberta Innovates; other supporters listed include Beresford Ventures, GoAhead Ventures, PharmStars, RK Hart Capital”
Your next opportunity is in here somewhere. Sign up to explore 68,000+ startups and their open roles. No spam. No gamification. Just jobs.
68,000+
Startups
69,000+
Open Roles
2,600+
New This Week
| Company |
|---|